Co-Diagnostics Inc (NASDAQ:CODX) price on Thursday, July 03, fall -3.15% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.28.
A look at the stock’s price movement, the close in the last trading session was $0.29, moving within a range at $0.277 and $0.3. The beta value (5-Year monthly) was 0.578. Turning to its 52-week performance, $2.23 and $0.23 were the 52-week high and 52-week low respectively. Overall, CODX moved -2.36% over the past month.
Co-Diagnostics Inc’s market cap currently stands at around $9.34 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-08.
Analysts have a consensus estimate of 300k for the company’s revenue for the quarter, with a low and high estimate of 300k and 300k respectively. The average forecast suggests down to a -88.71% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 950k, representing a -75.74% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CODX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
CODX’s current price about -0.83% and -8.08% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 47.67, while 7-day volatility ratio is 9.61% and 8.96% in the 30-day chart. Further, Co-Diagnostics Inc (CODX) has a beta value of 0.52. Analysts have given the company’s stock an average 52-week price target of $6, forecast between a low of $6 and high of $6. Looking at the price targets, the low is -2042.86% off current price level while to achieve the yearly target high, price needs to move -2042.86%. Nonetheless, investors will most likely welcome a -2042.86% jump to $6 which is the analysts’ median price.
If we refocus on Co-Diagnostics Inc (NASDAQ:CODX), historical trading data shows that trading volumes averaged 0.36 over the past 10 days and 378.89K over the past 3 months. The company’s latest data on shares outstanding shows there are 33.57 million shares.
The 9.00% of Co-Diagnostics Inc’s shares are in the hands of company insiders while institutional holders own 17.44% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.28 million on 2025-06-13, giving us a short ratio of 0.41. The data shows that as of 2025-06-13 short interest in Co-Diagnostics Inc (CODX) stood at 91.0 of shares outstanding, with shares short rising to 0.17 million registered in 2025-05-15. Current price change has pushed the stock -78.02% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CODX stock continues to rise going into the next quarter.
